04/10/2026, Lindsay Clark, "Advances in Alzheimer’s Disease Biomarker Testing: Psychosocial and Behavioral Implications of Early Detection" | UW–Madison ICEP

Describe the biological diagnosis and staging criteria for Alzheimer’s disease and available biomarker tests.
Evaluate potential risks and benefits associated with biomarker testing in predementia populations.
Assess current evidence on psychosocial and behavioral outcomes of biomarker testing in asymptomatic and symptomatic populations.

Session date:

04/10/2026 - 10:00am to 11:00am CDT

Location:

Virtual

United States

See map: Google Maps

1.00 APA CE Credits
1.00 University of Wisconsin–Madison Continuing Education Hours

Add to calendar:

Please login or register to take this course.

Discloser List CME Internal Report